FDA Inspection 1163918 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on Feb 25, 2022 in Beaumont, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 25, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Beaumont, TX (United States)